Works matching IS 10870156 AND DT 2014 AND VI 32 AND IP 2
Results: 42
BIO response to December editorial.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 131, doi. 10.1038/nbt.2818
- By:
- Publication type:
- Article
Recent patent applications in immunostaining.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 135, doi. 10.1038/nbt.2829
- Publication type:
- Article
UK boosts discovery tools.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 119, doi. 10.1038/nbt0214-119b
- By:
- Publication type:
- Article
Illumina claims $1,000 genome win.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 115, doi. 10.1038/nbt0214-115a
- By:
- Publication type:
- Article
Investor stampede for CARs.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 112, doi. 10.1038/nbt0214-112
- By:
- Publication type:
- Article
Celgene's multibillion spree on Oncomed/NYC.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 116, doi. 10.1038/nbt0214-116a
- By:
- Publication type:
- Article
PIQ-ing into chromatin architecture.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 138, doi. 10.1038/nbt.2824
- By:
- Publication type:
- Article
Innovative startups 2013.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 127, doi. 10.1038/nbt.2807
- By:
- Publication type:
- Article
What's in a name?
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 132, doi. 10.1038/nbt.2819
- By:
- Publication type:
- Article
Fresh from the biotech pipeline-2013.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 121, doi. 10.1038/nbt.2811
- By:
- Publication type:
- Article
Shire shifts towards rare diseases.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 114, doi. 10.1038/nbt0214-114
- By:
- Publication type:
- Article
Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 171, doi. 10.1038/nbt.2798
- By:
- Publication type:
- Article
Fourth-quarter biotech job picture.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 199, doi. 10.1038/nbt.2814
- By:
- Publication type:
- Article
Single-molecule site-specific detection of protein phosphorylation with a nanopore.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 179, doi. 10.1038/nbt.2799
- By:
- Publication type:
- Article
Computational resources for high-dimensional immune analysis from the Human Immunology Project Consortium.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 146, doi. 10.1038/nbt.2777
- Publication type:
- Article
Nature Biotechnology responds.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 132, doi. 10.1038/nbt.2822
- Publication type:
- Article
2013-biotech back in the saddle.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 126, doi. 10.1038/nbt.2826
- By:
- Publication type:
- Article
Boston quartet revamps biopsies.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 118, doi. 10.1038/nbt0214-118
- By:
- Publication type:
- Article
Drug pipeline 4Q13.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 125, doi. 10.1038/nbt.2815
- By:
- Publication type:
- Article
Amgen response to December editorial.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 131, doi. 10.1038/nbt.2817
- By:
- Publication type:
- Article
Pharmaceutical and biotech product patents in India: doldrums or blissfulness?
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 133, doi. 10.1038/nbt.2809
- By:
- Publication type:
- Article
People.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 200, doi. 10.1038/nbt.2830
- Publication type:
- Article
Imbruvica-next big drug in B-cell cancer-approved by FDA.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 113, doi. 10.1038/nbt0214-113
- By:
- Publication type:
- Article
Biologic product identification and US pharmacovigilance in the biosimilars era.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 128, doi. 10.1038/nbt.2823
- By:
- Publication type:
- Article
Milestone approval lifts Illumina's NGS from research into clinic.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 111, doi. 10.1038/nbt0214-111
- By:
- Publication type:
- Article
Bispecific antibodies with native chain structure.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 136, doi. 10.1038/nbt.2812
- By:
- Publication type:
- Article
Setback for JAK2 inhibitors.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 119, doi. 10.1038/nbt0214-119a
- By:
- Publication type:
- Article
Around the world in a month.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 120, doi. 10.1038/nbt0214-120
- Publication type:
- Article
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 191, doi. 10.1038/nbt.2797
- By:
- Publication type:
- Article
Of snowflakes and natural killer cell subsets.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 140, doi. 10.1038/nbt.2810
- By:
- Publication type:
- Article
Master Protocol for squamous cell lung cancer readies for launch.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 116, doi. 10.1038/nbt0214-116b
- By:
- Publication type:
- Article
Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 149, doi. 10.1038/nbt.2783
- By:
- Publication type:
- Article
PARP inhibitors' revival.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 115, doi. 10.1038/nbt0214-115b
- By:
- Publication type:
- Article
In this issue.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. vii, doi. 10.1038/nbt.2827
- Publication type:
- Article
The promise and challenge of high-throughput sequencing of the antibody repertoire.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 158, doi. 10.1038/nbt.2782
- By:
- Publication type:
- Article
Smac mimetics and innate immune stimuli synergize to promote tumor death.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 182, doi. 10.1038/nbt.2806
- By:
- Publication type:
- Article
New dimensions in immunology.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 145, doi. 10.1038/nbt.2795
- Publication type:
- Article
Search and development.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 109, doi. 10.1038/nbt.2832
- Publication type:
- Article
A divided INN crowd.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 130, doi. 10.1038/nbt.2820
- By:
- Publication type:
- Article
A one-two punch knocks out biofilms.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 142, doi. 10.1038/nbt.2813
- By:
- Publication type:
- Article
It's official: biologics are pharma's darlings.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 117, doi. 10.1038/nbt0214-117
- By:
- Publication type:
- Article
Research Highlights.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 138, doi. 10.1038/nbt.2821
- Publication type:
- Article